Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1992Molecular and Cellular BiologyOpen Access

The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.

View Full Paper
Ask AI
Bookmark
Share

Authors

SKShannon C. KenneyUniversity of Wisconsin–MadisonEHElizabeth Holley-GuthrieUniversity of North Carolina at Chapel HillEQE. Byrd QuinlivanUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kenney et al. (1992) studied this question.

synapsesocial.com/papers/6a707adbf44fa9f079de20e2https://doi.org/10.1128/mcb.12.1.136
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter.1990 · 84 citations
  2. 2DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB.1990 · 106 citations
  3. 3Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required1991 · 78 citations
  4. 4Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells1982 · 3,106 citations
  5. 5Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.1982 · 7,748 citations